The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List
ChartZero.com
ChartZero

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Wed., Jul. 23, 9:41 AM

Slide #25. bluebird bio, Inc. Secondary Offering

Company: bluebird bio, Inc. (NASDAQ:BLUE)
Date announced: 7/7/2014
Shares Offered: 3,000,000
Date of Pricing: 7/8/2014
Price Per Share: $34.00
Secondary Offering Details: bluebird bio, Inc. (NASDAQ:BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today announced that it has commenced an underwritten public offering of $100 million of its common stock. bluebird bio also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering. - updated 7/9 - bluebird bio, Inc. (NASDAQ:BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and orphan diseases, today announced the pricing of an underwritten public offering of 3,000,000 shares of its common stock at a public offering price of $34.00 per share, before underwriting discounts. In addition, bluebird bio has granted the underwriters a 30-day option to purchase from it up to an additional 450,000 shares of common stock.

Bluebird Bio is a clinical-stage biotechnology company focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy. Many diseases have a genetic aspect whereby a mutated gene linked to a disease is passed down from generation to generation and causes the disease. In the gene transfer process, a functional gene is delivered and incorporated into a patient's cells through a delivery system called a vector, which are most commonly based on naturally-occurring viruses that have been modified to take advantage of the virus' natural ability to introduce genes into cells.
Open the BLUE Page at The Online Investor »

Company Name:  bluebird bio Inc
Website:  www.bluebirdbio.com
Sector:  Biotechnology
Number of ETFs Holding BLUE:  15
Total Market Value Held by ETFs:  $25.49M
Total Market Capitalization:  $831.00M
% of Market Cap. Held by ETFs:  3.07%
 

Open the BLUE Page at The Online Investor (in a new window) »

July 23, 2014    9:41 AM Eastern
Quotes delayed 20 minutes



Strong Buy (4.00 out of 4)
88th percentile
(ranked higher than approx. 88% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | www.TheOnlineInvestor.com | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.